News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osmotics Pharma, Inc. (OPI) And OnSource Corporation (OSCE.OB) Complete Merger



10/19/2005 5:10:15 PM

DENVER, May 11, 2005 (PRIMEZONE) -- OnSource Corporation ("OnSource") (OTCBB:OSCE) has completed its planned merger with Osmotics Pharma, Inc. ("OPI"), a specialty pharmaceutical company focused on dermatology, oncology and infectious disease. Pending approval from OnSource's shareholders, the company intends to change its name and operate under the name Ceragenix Pharmaceuticals.

Read at Prime Zone

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES